ATGC holds key technologies that empower us to develop innovative products and offer cutting edge services.
- Gene editing technology miCas9
- Monoclonal antibody platform SBEAD
- Embryonic stem cells
Services
Monoclonal antibody development
Antigen design, peptide synthesis and conjugation
Antibody humanization
Biological conjugation of antibody
Animal embryo cryopreservation
Transgenic animal production
Address: 1004 W 9th Avenue, Suite 10, King of Prussia, PA 19406, USA | Email: info@atgcinc.com